values derived from these plots were not significantly affected by age. Similarly, zinc inhibited binding in a dosedependent fashion and was also unaffected by age. These data indicate that the NMDA receptor is spared in aging.
UMAN aging is associated with a mild slowing of both reaction time and motor speed, as well as a decline of complex cognitive skills (1) . There is also an increased risk of ischemic stroke and neurodegenerative disease with advancing age (2) . Excitatory amino acid (EAA) neurons and receptors, particularly the N-methyl-D-aspartate (NMDA) receptor, have been implicated in cognitive function, ischemic stroke, and neurodegenerative disease (3) . Assessment of EAA neurons with aging has, because of difficulty assessing EAA neurons in postmortem human brain, largely relied on examination of experimental animals (2) whereas the NMDA receptor has been successfully assessed in both humans and experimental animals (2) .
Investigations of the NMDA receptor have been greatly facilitated by the availability of compounds such as dizo- (4) (5) (6) . Thus, in well-washed brain membrane preparations, [ 3 H]-dizocilpine binding can be used to provide an index of the open state of the NMDA-operated channel and thus serve as a tool to examine the capacity of the receptor to respond to modulatory influences. The activity of the NMDA-receptor channel is regulated by a number of subsites, including a transmitter binding site that binds L-glutamate or L-aspartate (7), a co-agonist site that binds glycine (5, 6, 8) , a voltagedependent magnesium binding site (9, 10) , an inhibitory divalent cation modulatory site that binds zinc (11, 12) , and a positive modulatory site that binds polyamines such as spermine and spermidine (6, 13) . [ 3 H]-dizocilpine binding has been shown to be increased by glutamate, glycine, and polyamines and decreased by Zn 2 ϩ (5, 6, 13, 14) . This study uses [ 3 H]-dizocilpine binding to investigate the integrity of the co-agonist site of the NMDA receptor, in conjunction with polyamine and zinc modulatory sites, in the long-lived Fischer 344/Norwegian brown strain of rat aged 3, 12, 24, and 37 months. An assessment of excitatory amino acid nerve terminals in these animals has previously been published (15) .
M ETHODS
Male hybrid Fischer 344/Norwegian Brown rats aged 3, 12, 24, and 37 months were obtained from the National Institute on Aging colonies (Bethesda, MD) and were used within 2 weeks of arrival. Animals were maintained on a 12-hour light-dark cycle with free access to food and water. Following decapitation, the neocortex was dissected free of white matter on an ice-chilled inverted petri dish and then frozen ( Ϫ 80 Њ C). Membranes were prepared and assays performed, as described previously (16) . Briefly, using wellwashed membranes, binding assays were performed in a 0.4 ml final volume of 5 mM Tris-acetate (pH 7.4) for 1 hour at 25 Њ C. Assays used 5 nM [ 3 H]dizocilpine and drugs, dissolved in Tris-acetate buffer, as appropriate. Nonspecific binding was defined by 100 M dizocilpine and represented 10% of total binding. Curves monitoring the effects of arcaine were performed in the presence of both 100 M glutamate and 30 M glycine to preclude actions at glutamate and glycine sites and to reduce the influence of variable amounts of amino acids in the tissue samples. It is unlikely that these conditions measure [ 3 H]dizocilpine binding at equilibrium. However, by monitoring nonequilibrium conditions it is possible to detect the agonist actions of glycine and polyamines as well as the antagonist actions of the competitive polyamine site antagonist arcaine and the divalent cation zinc (5, 6, 17) . Glycine enhancement of binding was determined as fold increase according to the following equation: fold increase ϭ (maximal binding ϩ basal binding)/basal binding, where maximal binding is binding in the presence of 100 M glutamate and 30 M glycine and basal binding is binding in the presence of 100 M glutamate. Inhibition of binding was quantified by determining values from Hill plots using Accufit-competition software (Lundon Software, Chagrin Falls, OH). Protein concentrations were determined as described previously (16) 50 values derived from these plots were not significantly affected by age. Zinc inhibited binding in a dose-dependent fashion, as shown previously (14) , but this inhibition was unaffected by age. The absence of a statistically significant effect of age is supported by the absence of any clear trends when mean values are compared across the four age groups.
D ISCUSSION
Using [ 3 H]dizocilpine binding, this study has shown that there was no effect of aging on either the glycine co-agonist site or the polyamine and zinc modulatory sites of the NMDA receptor in neocortex of Fischer 344/Norwegian Brown rats aged 3, 12, 24 and 37 months. Binding in the presence of 100 M glutamate alone was also unaffected by age. Together, these data suggest a preservation of the NMDA receptor with aging. This is in agreement with the study of Shimada and colleagues (18) , who showed no change in [ 3 H]dizocilpine binding in the frontal cortex of Sprague-Dawley rats aged 2, 8, and 25 months. However, Tamaru and colleagues (19) found diminished [ 3 H]dizocilpine binding (in the presence of both glutamate plus glycine and glutamate plus glycine plus spermidine) in neocortex of Fischer 344 rats aged 7 and 29 months when compared with animals aged 3 months. These changes were more pronounced in the presence of spermidine than in the absence of this polyamine. The actions of polyamines at the NMDA receptor are complex and consist of both stimulatory and inhibitory components (6, 13, 17) . It is therefore possible that this confounded the study of Tamaru and colleagues (19) . Because arcaine appears to inhibit the stimulatory actions of polyamines (which predominate at lower concentrations) without affecting the inhibitory actions (17) , its use in the present study probably provides a more reliable measure of the polyamine site of the NMDA receptor and is consistent with competitive antagonism of the increase in binding produced by spermidine. Age-associated reductions in [ 3 H]CPP and [ 3 H]glycine binding to the NMDA receptor were reported by Kito and colleagues (20) , but because these changes reflected differences from animals aged 2 months of age and the process of brain maturation may not be complete until 12 months (21), it seems likely that their results reflect changes occurring as a result of brain maturation rather than senescence. Similarly, the autoradiographic study of Mitchell and Anderson (22) showed reduced [ 3 H]dizocipline binding in the inner frontal cortex and the entorhinal cortex of animals aged 12 and 24 months when compared with animals aged 6 months. The possibility of such false positive data has been minimized in the present study by examining 3 groups of animals aged 12 months or older. It is also possible that the discrepancy between the autoradiographic study of Mitchell and Anderson and the present study of well-washed cortical membranes is attributable to methodological differences, or it may be a consequence of age-related changes occurring only in discrete regions of cortex and therefore not apparent when the whole neocortex is assessed.
In conclusion, like EAA nerve terminals (15; which were assessed in the same animals), the glycine, polyamine and zinc subsites of the NMDA receptor in rat neocortex are spared in aging. Data are expressed as mean Ϯ SEM (with number of animals in parentheses). Assay conditions are described in the text. Briefly, specific binding of [ 3 H]dizocilpine (5 nM) was determined in incubations containing 100 M glutamate and 30 M glycine. IC 50 values were then calculated for arcaine, arcaine plus spermidine and zinc. There was no significant effect of age on any of the parameters assessed ( p Ͼ .1, ANOVA).
